Literature DB >> 19145996

A grading scale for epistaxis in hereditary haemorrhagic teleangectasia.

S Al-Deen1, G Bachmann-Harildstad.   

Abstract

BACKGROUND: Epistaxis is the most common symptom in patients with Hereditary Haemorrhagic Telangiectasia (HHT). Different institutions are using different treatment modalities and different grading systems. The treatment options depend on the grade of epistaxis. It is important to have a common grading system to compare and evaluate the effectiveness of different treatment options. Furthermore, it is important to correlate quality of life with an epistaxis grading system. The aim of this work was to propose a new grading system for epistaxis in HHT.
METHODS: A medical literature search was performed for grading systems of epistaxis in HHT. A questionnaire on five criteria's for a new grading system was sent to 22 internationally renowned medical experts, who have published results on epistaxis in HHT.
RESULTS: Four different grading systems are currently in use for the grading of epistaxis in HHT. The response rate of the questionnaire was 43%. All the experts who answered the questionnaire agreed that the aimed grading system should be easy to understand for the patients. 90% of them wanted the system to focus on a definite time period. 70% answered that blood transfusion should be included in the grading system as an important factor. There was no clear consensus on whether the system should be a single multi-item scale or a composite scale consisting of more than one single scales, and similarly there was no clear consensus on whether is should be an absolute or a relative scale.
CONCLUSION: The proposed system should be easy to understand for the patients, focus on a definite time period of observation, and include blood transfusion as one of its parameters. For statistical reasons, an epistaxis grading scale with at least one absolute end point would be preferable.

Entities:  

Mesh:

Year:  2008        PMID: 19145996

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  3 in total

1.  Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia.

Authors:  Gita Jørgensen; Bibi Lange; Jens Højberg Wanscher; Anette Drøhse Kjeldsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-26       Impact factor: 2.503

2.  Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT.

Authors:  Thi Thao Truc Le; Guillaume Martinent; Sophie Dupuis-Girod; Antoine Parrot; Anne Contis; Sophie Riviere; Thierry Chinet; Vincent Grobost; Olivier Espitia; Brigitte Dussardier-Gilbert; Laurent Alric; Guillaume Armengol; Hélène Maillard; Vanessa Leguy-Seguin; Sylvie Leroy; Murielle Rondeau-Lutz; Christian Lavigne; Shirine Mohamed; Laurent Chaussavoine; Pascal Magro; Julie Seguier; Mallorie Kerjouan; Sylvie Fourdrinoy
Journal:  Orphanet J Rare Dis       Date:  2022-07-19       Impact factor: 4.303

3.  Nosebleeds in hereditary hemorrhagic telangiectasia: Development of a patient-completed daily eDiary.

Authors:  Marci Clark; Pamela Berry; Susan Martin; Nimanee Harris; Dennis Sprecher; Scott Olitsky; Jeffrey B Hoag
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.